Tao X, Li Y, Fan S, Wu L, Xin J, Su Y, Xian X, Huang Y, Huang R, Fang W, Liu Z. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma. J Exp Clin Cancer Res. 2023 Jan 10;42(1):12. IF=11.300.
Li F, Yang J, Li Y, Tan Z, Li H, Zhang N. Long non-coding RNA FENDRR suppresses cancer-associated fibroblasts and serves as a prognostic indicator in colorectal cancer. Transl Oncol. 2023 Oct;36:101740. IF=5.000.
Han W, Shi CT, Chen H, Zhou Q, Ding W, Chen F, Liang ZW, Teng YJ, Shao QX, Dong XQ. Role of LncRNA MIR99AHG in breast cancer: Bioinformatic analysis and preliminary verification. Heliyon. 2023 Sep 4;9(9):e19805. IF=4.000.
Xu Q, Lu X, Li J, Feng Y, Tang J, Zhang T, Mao Y, Lan Y, Luo H, Zeng L, Xiang Y, Hu L, Zhang Y, Li Q, Deng L, He X, Tang B, Mao X, Zeng D. Fusobacterium nucleatum induces excess methyltransferase-like 3-mediated microRNA-4717-3p maturation to promote colorectal cancer cell proliferation. Cancer Sci. 2022 Nov;113(11):3787-3800. IF=5.700.
Lin Y, Zhou Z, Xie L, Huang Y, Qiu Z, Ye L, Cui C. Effects of miR-939 and miR-376A on ulcerative colitis using a decoy strategy to inhibit NF-κB and NFAT expression. Eur J Histochem. 2022 Feb 15;66(1):3316. IF=2.000.
Wang S, Lin Y, Li F, Qin Z, Zhou Z, Gao L, Yang Z, Wang Z, Wu B. An NF-κB-driven lncRNA orchestrates colitis and circadian clock. Sci Adv. 2020 Oct 14;6(42):eabb5202. IF=13.600.
Wu Z, Luo J, Huang T, Yi R, Ding S, Xie C, Xu A, Zeng Y, Wang X, Song Y, Shi X, Long H. MiR-4310 induced by SP1 targets PTEN to promote glioma progression. Cancer Cell Int. 2020 Dec 17;20(1):567. IF=5.800.
Tang T, Wang LX, Yang ML, Zhang RM. lncRNA TPTEP1 inhibits stemness and radioresistance of glioma through miR‑106a‑5p‑mediated P38 MAPK signaling. Mol Med Rep. 2020 Dec;22(6):4857-4867. IF=3.400.